Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team

Size: px
Start display at page:

Download "Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team"

Transcription

1

2 Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team

3 Drugs play a major role in both treating and causing renal disease Doses of some drugs need to be changed in renal disease Clearance of drugs is different again in dialysis Renal pharmacists can help with doses and drug choice

4 Controls the water and electrolyte content of the body By filtration, secretion and reabsorption Keeps vital substances (e.g. protein) in the body Maintains the acid-base balance Excretes waste products, toxins and drugs Endocrine functions Activates Vitamin D Produces hormones (e.g. Erythropoeitin)

5 Acute Kidney Injury (AKI) Can be caused by drugs, sepsis, trauma Chronic Kidney Disease (CKD) Staged according to renal function Causes Inherited disease (e.g. polycystic kidneys) Acquired disease (e.g. nephrotic syndrome) Hypertension Diabetes

6 Treatment can be for the underlying disease e.g. cyclophosphamide to treat vasculitis Most drugs are aimed at treating the complications of renal disease EPO for renal anaemia Phosphate binders for renal bone disease ACE-I for protein loss in nephrotic syndrome Renal patients often have multiple comorbidities, so we need to consider their other treatments too

7 In renal failure, drugs are handled differently by the body Reduced absorption Increased permeability of the blood brain barrier Reduced protein binding Reduced metabolism Reduced clearance of drugs Doses of some drugs need to be altered in renal failure

8 Is the drug nephrotoxic? Avoid where possible e.g. Ciprofloxacin instead of Gentamicin Less of an issue if anuric Is the drug excreted unchanged in the urine? Ideally <25% Risk of accumulation Lower dose needed for same effect

9 How are metabolites excreted? Very little significant metabolism by the kidney Active metabolites may accumulate in ESRF E.g. Morphine-6-glucuronide Is there significant non-renal toxicity? If wide therapeutic window, e.g. Penicillins, dose adjustment may not be necessary Caution with LMWHs as CKD patients already at higher bleeding risk

10 The degree that the dose needs to be adjusted is according to an estimation of the patient s renal function Resources Renal Drug Handbook BNF Manufacturer s information Renal Pharmacist

11 MDRD Equation Reported on the VitalData/ CWS Not validated for drug dosing BSA = 1.73m 2 Cockcroft and Gault Equation Used for drug dosing Esp when narrow therapeutic index CrCl = (140 Age) x Weight(kg) x g Serum Creatinine g... Men = 1.23 Women = 1.04

12 Is the drug removed by dialysis? If not it doesn t matter when you give it If it is, give after if it is a ONCE daily drug This information is in the Renal Drug Handbook Peritoneal dialysis does not remove drugs, Dose as in ESRF

13 The extent to which drugs are removed by haemodialysis depends on Size of the drug (MW<500) Protein binding In plasma or tissue? High water solubility Low volume of distribution If the drug is only removed by HD, it should be only be given after dialysis e.g. Vancomycin (see ward protocol)

14 Dose 1 HD day or non-hd day Vancomycin 1g (patient <70kg) Vancomycin 1.5g (patient kg) Vancomycin 2g (patient >100kg) Dose 2 With next HD session And plan to give vancomycin with every subsequent haemodialysis session Dose 3 With next HD session Dose 4 With next HD session Vancomycin 750mg (patient <70kg) Vancomycin 1g (patient kg) Vancomycin 1.5g (patients >100kg) Check vancomycin level prior to next HD session Do not wait for levels before giving vancomycin Dose 3 Vancomycin 750mg (patient <70kg) Vancomycin 1g (patient kg) Vancomycin 1.5g (patients >100kg) Prescribe Dose 4, 5 and 6 according to vancomycin levels (mg/l) taken prior to Dose 3 Aim to maintain vancomycin levels of 15-20mg/L Vancomycin administration: 500mg or 750mg infuse in 100ml sodium chloride 0.9% during last 60 minutes of HD 1g infuse in 250ml sodium chloride 0.9% during last 90 mins 1.5g infuse in 250ml sodium chloride 0.9% during last 120 mins 2g infuse in 250ml sodium chloride 0.9% during last 150 mins < 5 Vanc 1.5g (1g if <70kg) Seek advice for subsequent antibiotic plan 5 to 9 Vanc 1.5g (1g if <70kg) 10 to 14 Vanc 1g 15 to 20 Vanc 750mg 21 to 25 Vanc 500mg > 25 Hold dose Dose 5 and Dose 6 With next two HD sessions Repeats of Dose 4 (except when vancomycin level >25mg/L prior to Dose 3) Vanc 1.5g (1g if <70kg) Vanc 1g Vanc 750mg Vanc 500mg Check vancomycin level prior to Dose 6 (take level before starting the HD session) Do not wait for levels before giving vancomycin Dose 6 Vanc 500mg Dose 7 With next HD session Prescribe Dose 7, 8 and 9 according to vancomycin levels (mg/l) taken prior to Dose 6 (see above) Aim to maintain vancomycin levels of 15-20mg/L Dose 8 and beyond Continue to prescribe vancomycin according to this guidance Check vancomycin levels prior to every 3 rd HD session (generally once weekly)

15 Uraemia Toxins can displace drugs from binding sites Leads to increased free drug levels Proteinuria Low plasma albumin levels an issue with drugs which are highly protein bound Leads to increased free drug levels Poor urine concentrating ability Nitrofurantoin relies on this, therefore ineffective when egfr <45ml/min

16 Tubular dysfunction Avoid thiazide diuretics when egfr <30ml/min Fluid restriction Consider volume of IV drugs Sodium content (e.g. Disp paracetamol) Drugs requiring constant fluid status (e.g. Li) Oedema Gut oedema can reduce GI drug absorption

17 Erythropoeitin deficiency Occurs early in CKD Replace with synthetic ESA Need to ensure adequate iron stores prior to starting Eprex First line ESA for haemodialysis patients Short acting, 1-3x/week dosing Start at units two-three times a week Mircera First line ESA for pre-dialysis, RTx and PD Long acting; monthly dosing Start around 50-75mcg (depending on wt)

18 Iron deficiency NICE 2015 put more emphasis on iron status Ferritin and TSATs Unit HD patients get Venofer on HD Others get TDI (Ferinject or Monofer) Vitamin B 12 deficiency Folate deficiency

19

20 Phosphate Binders No point taking them if not with food! First line... Calcium containing binders Calcichew, Calcium acetate If Calcium high, concerns re calcification... Alucaps, Lanthanum, Sevelamer Vitamin D analogues Alfacalcidol, calcitriol Colecalciferol??? Hyperparathyroidism Parathyroidectomy Cinacalcet

21 Calcification of blood vessels and soft tissue Treatment Pain relief Stop warfarin As much dialysis as possible Sodium thiosulphate 50ml of 50% solution (25g) after HD

22 Tinzaparin first line across N&T Doses according to time on HD initially Adjusted to clinical signs (e.g streaking, bleeding) Check with satellite unit on admission Some patients on heparin/ fondaparinux If on treatment dose Clexane, don t need extra anticoagulation on HD First line line lock = Citralock All should be prescribed on drug chart

23 AVF is best access option Better pump speeds Less risk of infection Blocked lines Algorithm... Check for mechanical issues Urokinase Protocol 3 push locks and 1 infusion = senior review Line sepsis Vancomycin for empirical treatment Blood cultures guide further treatment

24 Antibiotic stickers MicroGuide Includes N&T guidance and dosing Restricted antibiotics vuhb/adult Sepsis bundle

25 Guidance on MicroGuide Empirical treatment IP Vancomycin in one bag every 5-7 days PO Ciprofloxacin Further Abx guided by PD fluid/ blood cultures Should be prescribed on main drug chart as well as on PD chart Disconnection/ contamination of line

26 Types of donors Live donor Donors after Brain Death (DBD) Donors after Cardiac Death (DCD) Anti-rejection drugs Reduce risk of acute rejection i.e immune system attacking new kidney Doses must not be missed

27 Tacrolimus Prescribed by brand Adoport, Prograf, Advagraf, Envarsus Doses 12 hours apart (empty stomach) Pre-dose level Lots of drug-drug interactions Mycophenolate mofetil Doses 12 hours apart GI side effects (may switch to Myfortic) Increased risk of cancer SPF 50

28 Prednisolone Best taken in morning with breakfast Gradual reduction (unless short course) Often given omeprazole for gastroprotection Ciclosporin Only used in transplants from ages ago Similar issues to Tacrolimus Azathioprine Likewise, unless once daily preferable or pregnancy (in place of MMF) Sirolimus Used in place of tacrolimus to avoid nephrotoxicity Also needs pre-dose levels

29 Increased risk of infection if taking immunosuppression Pneumocystis jirovecii (PJP AKA PCP) Co-trimoxazole for 6 months 480mg daily (960mg MWF if cyclophosphamide) Cytomegalovirus (CMV) Valganciclovir for 3 months Dose depends on renal function Other prophylaxis given if patient at risk Donor history Hep B/C history in donor or recipient Either from area where TB endemic

30 Ward based roles Medicines reconciliation for all new patients Daily review of all charts Technician led non-stock top up TTHs at ward level Don t send down to pharmacy, bleep us Transplant clinic Prescription and supply of all anti-rejection drugs for all transplant patients Annual review, medication counselling, queries re drug choice

31 Home therapies Iron prescribing, nocturnal HD medication review Renal medication queries Via ward, HD units, Drs, nurses, other pharmacists, patients Directorate level roles Expenditure reporting Service development

32 Used for medicines management Drs now do electronic TTHs Signed off by pharmacist on WCP Ward view to see which TTHs have been seen by pharmacy team Can t tell you whether they have been dispensed though! Can also access old TTHs, GP record

33 Rob Bradley Bleep 5707 Helen Thomas Bleep 6351 Hayley Jones Bleep 6360 Jenna Walker Bleep 6359 Gareth Bryant Bleep???? Edwina Jenkins Bleep 6523 Clinic pharmacy Ext 41222

34

Medicines for anaemia and mineral bone disease

Medicines for anaemia and mineral bone disease Patient Information: Medicines NHS Logo here Medicines for anaemia and mineral bone disease Health & care information you can trust The Information Standard Certified Member Working together for better

More information

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE

More information

What is this leaflet about?

What is this leaflet about? Patient Information: Medicines Medicines commonly taken by people after a transplant or with an autoimmune disease Health & care information you can trust The Information Standard Certified Member Working

More information

Common Medication for People Receiving Haemodialysis

Common Medication for People Receiving Haemodialysis Common Medication for People Receiving Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow CKD - KDIGO Definition and Classification of CKD CKD: abnormalities of kidney structure/function for > 3 months with health implications 1 marker

More information

Clinical guidance for the management of. Cytomegalovirus (CMV) in. kidney/pancreas transplant patients. Guidance prepared by Cardiff and Vale UHB

Clinical guidance for the management of. Cytomegalovirus (CMV) in. kidney/pancreas transplant patients. Guidance prepared by Cardiff and Vale UHB Clinical guidance for the management of Cytomegalovirus (CMV) in kidney/pancreas transplant patients Guidance prepared by Cardiff and Vale UHB Kidney/Pancreas Transplant Virus MDT Sarah Browne (Consultant

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Presence of kidney damage or decreased kidney function for three or more months, - necessary to distinguish CKD from acute kidney disease. Ascertained either by kidney biopsy or

More information

After a kidney transplant

After a kidney transplant The nursing staff will make sure that you are comfortable and will monitor the transplanted kidney to make sure it is working well. When you wake up you will notice that you will have a number of different

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult) VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin

More information

Clinical Guideline Bone chemistry management in adult renal patients on dialysis

Clinical Guideline Bone chemistry management in adult renal patients on dialysis Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L

More information

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title

More information

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04 Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: AZATHIOPRINE Protocol number: CV 04 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION LIVER

More information

EFFECTIVE SHARE CARE AGREEMENT

EFFECTIVE SHARE CARE AGREEMENT Specialist details Patient identifier Name: Tel: EFFECTIVE SHARE CARE AGREEMENT For the specialist use of Erythropoietin Stimulating Agent (ESA) Therapy (formerly known as EPO) for the correction of Anaemia

More information

Analgesia in patients with impaired renal function Formulary Guidance

Analgesia in patients with impaired renal function Formulary Guidance Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function

More information

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes

More information

Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree

Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines

More information

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal

More information

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR CHRONIC KIDNEY DISEASE Contents Stages of Chronic Kidney Disease Dosing adjustments Hyperphosphataemia management Secondary hyperparathyroidism Anaemias Hyperkalaemia Acidosis Hypertension STAGES OF CHRONIC

More information

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE CHRONIC KIDNEY DISEASE 1 This information is intended to help you understand why you need to take your medicines. There are multiple medicines that are used to control the symptoms related to CKD. You

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Chronic Kidney Disease in Primary Care

Chronic Kidney Disease in Primary Care Clinical Stream Chronic Kidney Disease in Primary Care Dr Gerald Waters Dr Gerald Waters Renal Physician Chronic Kidney Disease Chronic Kidney Disease Normal functions of Kidneys Management of CKD Drugs

More information

Dialysis: the long case

Dialysis: the long case Dialysis: the long case Prof Mark Brown St George Public Hospital, Kogarah The case SD 1. What significant things have been omitted from the history? 2. Physical findings 70 RTA; mitral regurg murmur;

More information

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if

More information

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: TACROLIMUS Protocol number: CV 43

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: TACROLIMUS Protocol number: CV 43 Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: TACROLIMUS Protocol number: CV 43 Indications: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION IN ADULTS.

More information

Disclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease

Disclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease Disclosures Chronic Kidney Disease Consultant: Baxter Healthcare J. Kevin Tucker, M.D. Brigham and Women s Hospital Massachusetts General Hospital Topics Staging of chronic kidney disease (CKD) How to

More information

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral

More information

Mycophenolate Mofetil (MMF)

Mycophenolate Mofetil (MMF) SCG: For Transplant patients The following guidelines are designed to provide information relating to mycophenolate mofetil and to outline the responsibilities of the primary and secondary care teams in

More information

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2. Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR

More information

StRs and CT doctors in haematology. September Folinic acid dose modified.

StRs and CT doctors in haematology. September Folinic acid dose modified. High dose Methotrexate and folinic acid rescue Full Title of Guideline: Author (include email and role): Division & Speciality: Clinical Guideline Review Date September 2018 GUIDELINE FOR THE USE OF HIGH

More information

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: CICLOSPORIN Protocol number: CV 06

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: CICLOSPORIN Protocol number: CV 06 Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: CICLOSPORIN Protocol number: CV 06 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION IN ADULTS

More information

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW: Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic

More information

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Information for patients The following pages offer you information on some of the medicines that you may need. It is

More information

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique

More information

Acute Kidney Injury shared guidance

Acute Kidney Injury shared guidance Acute Kidney Injury shared guidance Acute Kidney Injury (AKI) Fluid balance assessment (NICE CG 169) Assess the patient s likely fluid and electrolyte needs 1.History previous limited intake, thirst, abnormal

More information

Secondary Hyperparathyroidism: Where are we now?

Secondary Hyperparathyroidism: Where are we now? Secondary Hyperparathyroidism: Where are we now? Dylan M. Barth, Pharm.D. PGY-1 Pharmacy Resident Mayo Clinic 2017 MFMER slide-1 Objectives Identify risk factors for the development of complications caused

More information

Professor Suetonia Palmer

Professor Suetonia Palmer Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS

More information

NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion

NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion Acute Sector NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion Co-ordinators: Gillian Macartney Fiona McDonald Specialist Antibiotic

More information

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15 Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION

More information

PRESCRIBING IN LIVER AND RENAL DISEASE

PRESCRIBING IN LIVER AND RENAL DISEASE THERAPEUTICS FOR INDEPENDENT PRESCRIBERS PRESCRIBING IN LIVER AND RENAL DISEASE Number 6 in a series of 15 articles on Therapeutics Aims and Objectives To outline the pathophysiological changes that occur

More information

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47 MPharm Programme Acute Kidney Injury Alan M. Green 2017 Slide 1 of 47 Overview Renal Function What is it? Why does it matter? What causes it? Who is at risk? What can we (Pharmacists) do? How do you recognise

More information

HEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease

HEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy

More information

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY UK RENAL PHARMACY GROUP SUBMISSION TO THE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE on CINACALCET HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE

More information

5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.

5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors. Overview The Kidneys Nicola Barlow Clinical Biochemistry Department City Hospital Renal physiology Renal pathophysiology Acute kidney injury Chronic kidney disease Assessing renal function GFR Proteinuria

More information

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients A. WADGYMAR, MD Credit Valley Hospital, Mississauga, Ontario, Canada. June 1, 2007 1 Case: 22 y/o referred to Renal Clinic Case: A.M. 29 y/o Man

More information

Tacrolimus. Information for Parents/Carers

Tacrolimus. Information for Parents/Carers Tacrolimus Information for Parents/Carers St Michael s C Ward 01 878 4258 01 878 4431 Main Hospital Number 01 878 4200 What is tacrolimus and what is it used for? Tacrolimus is an immunosuppressant drug,

More information

Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients

Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients page 2 If you are on haemodialysis (HD) or peritoneal dialysis (PD) this leaflet is for you. It will provide you

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian Cheshire and Merseyside Renal Units Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (adapted from Greater Manchester) Authors Name: Christopher Wong: Consultant Nephrologist

More information

CHRONIC KIDNEY DISEASE (CKD)

CHRONIC KIDNEY DISEASE (CKD) CHRONIC KIDNEY DISEASE (CKD) CKD implies longstanding (more than 3 months), and usually progressive, impairment in renal function. In many instances, no effective means are available to reverse the primary

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

Understanding Your Medications

Understanding Your Medications PD Education Booklet 8 Understanding Your Medications What you will learn: Why your medications are important Medications your kidney doctor may prescribe, and what they do Medications that may be added

More information

Greater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Greater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) Greater Manchester Guidelines on the Management of (CKD-MBD) Classification: Clinical Guideline Lead Author: Smeeta Sinha, Consultant Nephrologist Additional author(s): Elizabeth Lamerton, Renal Pharmacist

More information

Renal Excretion of Drugs

Renal Excretion of Drugs Renal Excretion of Drugs 3 1 Objectives : 1 Identify main and minor routes of Excretion including renal elimination and biliary excretion 2 Describe its consequences on duration of drugs. For better understanding:

More information

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Paediatric Prescribing Pocket Guide September 2014 (Version 1) PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors

More information

Mycophenolate. Information for Parents/Carers

Mycophenolate. Information for Parents/Carers Mycophenolate Information for Parents/Carers St Michael s C Ward 01 878 4258 01 878 4431 Main Hospital Number 01 878 4200 What is mycophenolate and what is it used for? Mycophenolate is an immunosuppressant

More information

Trust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over)

Trust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over) Trust Guideline for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis (*ie aged 16 years and over) abc A guideline recommended for use In: Gastroenterology/Medical

More information

Filtration and Reabsorption Amount Filter/d

Filtration and Reabsorption Amount Filter/d Renal Physiology 2011 Lisa M. Harrison-Bernard, PhD Contact me at lharris@lsuhsc.edu Renal Physiology Lecture 3 Renal Clearance and Glomerular Filtration Filtration and Reabsorption Amount Filter/d Amount

More information

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist

More information

Tacrolimus (Adoport, Prograf, Modigraf or Advagraf )

Tacrolimus (Adoport, Prograf, Modigraf or Advagraf ) Shared Care Guideline DRUG: Tacrolimus (Adoport, Prograf, Modigraf or Advagraf ) for Renal Transplant (Adults) Introduction: Indication: Prophylaxis of transplant rejection in kidney recipients Tacrolimus

More information

Office Management of Reduced GFR Practical advice for the management of CKD

Office Management of Reduced GFR Practical advice for the management of CKD Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE

More information

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019 Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal

More information

PPP 1. Continuation, modification, and discontinuation of a medication

PPP 1. Continuation, modification, and discontinuation of a medication PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

The Renal System. David Carroll

The Renal System. David Carroll The Renal System David Carroll dcarroll06@qub.ac.uk https://www.davidontheinter.net Learning Objectives What you need to pass your exam Anatomy Physiology Pharmacology Pathophysiology Renal Anatomy Renal

More information

Medical Emergencies in Dialysis Patients

Medical Emergencies in Dialysis Patients Medical Emergencies in Dialysis Patients John Anderton Consultant Renal Physician Lancashire Teaching Hospitals NHS Foundation Trust Talk Plan A Flavour of Dialysis patients Emergencies in HD patients

More information

Ricky Bell Renal/ICM Registrar

Ricky Bell Renal/ICM Registrar Ricky Bell Renal/ICM Registrar Objectives When to call renal How to manage the patient with AKI How the manage the patient with CKD (HD/PD) Special AKI situations What do the guidelines say? My referral

More information

TRANSPLANTATION SERIES

TRANSPLANTATION SERIES TRANSPLANTATION SERIES What are the Complications of Transplantation Key points: Possible problems after a transplant Risks of immunosuppression General side effects of taking immunosuppressant drugs What

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Chronic Kidney Disease (CKD) Guideline (2010) Chronic Kidney Disease CKD: Executive Summary of Recommendations (2010) Executive Summary of Recommendations Below are the major recommendations

More information

Southern Trust Anticoagulant Team

Southern Trust Anticoagulant Team CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Anticoagulation- Primary Care Guidance for reviewing patients on DOACs Southern Trust Anticoagulant Team Haematology Acute

More information

TACROLIMUS (PROGRAF, Modigraf Adoport, Adagraf ) Prescribing Guidelines for Adult Liver Transplant Patients and autoimmune liver disease

TACROLIMUS (PROGRAF, Modigraf Adoport, Adagraf ) Prescribing Guidelines for Adult Liver Transplant Patients and autoimmune liver disease Oxford Gastroenterology Unit Shared Care Protocol & Information for GPs TACROLIMUS (PROGRAF, Modigraf Adoport, Adagraf ) Prescribing Guidelines for Adult Liver Transplant Patients and autoimmune liver

More information

Prescribing Framework for Mycophenolate Mofetil or Mycophenolic Acid (Myfortic ) Post Solid Organ Transplant

Prescribing Framework for Mycophenolate Mofetil or Mycophenolic Acid (Myfortic ) Post Solid Organ Transplant Hull & East Riding Prescribing Committee Prescribing Framework for Mycophenolate Mofetil or Mycophenolic Acid (Myfortic ) Post Solid Organ Transplant Patient s Name:.. NHS Number: Patient s Address:...

More information

Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant

Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant What is it? Why have I got it? How can we treat it? Why do I feel like I do? What do the blood tests mean? Will

More information

TDM. Measurement techniques used to determine cyclosporine level include:

TDM. Measurement techniques used to determine cyclosporine level include: TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.

More information

Gemcitabine, Carboplatin and Bevacizumab (gynae)

Gemcitabine, Carboplatin and Bevacizumab (gynae) Gemcitabine, Carboplatin and Bevacizumab (gynae) Indication Second line advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. WHO performance status 0 or 1. (Funding via the CDF) ICD-10

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

Definitions. You & Your New Transplant ` 38

Definitions. You & Your New Transplant ` 38 Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)

More information

GUIDELINES FOR BLOOD GROUP / ABO INCOMPATIBLE RENAL TRANSPLANTATION

GUIDELINES FOR BLOOD GROUP / ABO INCOMPATIBLE RENAL TRANSPLANTATION GUIDELINES FOR BLOOD GROUP / ABO INCOMPATIBLE RENAL TRANSPLANTATION Author: Contact Name and Job Title Dr Gavin McHaffie (Consultant Nephrologist) Ext 55932 Dr Alastair Ferraro (Consultant Nephrologist)

More information

THE KIDNEY AND SLE LUPUS NEPHRITIS

THE KIDNEY AND SLE LUPUS NEPHRITIS THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS

More information

NHS Lothian- University Hospitals Division

NHS Lothian- University Hospitals Division Pre-transplant ograph or Consultant Surgeon: Transplant Nurse: Consultant Diabetologist: Diabetes Specialist Nurse: Dietitian: NHS Lothian- University Hospitals Division Consultant Radiologist: Recipient

More information

Haemodialysis Blood Results

Haemodialysis Blood Results Haemodialysis Blood Results Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient information leaflets.htm Introduction

More information

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist Intervention Study 2016 West ISD Gillian Ritchie Clinical Pharmacist Introduction Annual data collection Two weeks All Medicines Management Team interventions Details recorded Classified by type Outcomes

More information

Chronic Kidney Disease Mineral Bone Disease

Chronic Kidney Disease Mineral Bone Disease NHS Logo here Chronic Kidney Disease Mineral Bone Disease (CKD-MBD) Patient Information Health & care information you can trust The Information Standard Certified Member Working together for better patient

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Acute Kidney Injury (AKI) Undergraduate nurse education

Acute Kidney Injury (AKI) Undergraduate nurse education Acute Kidney Injury (AKI) Undergraduate nurse education Year One Developed Summer 2017 Overview Basic A & P of: Urinary system Kidneys Followed by: Introduction to Acute Kidney Injury Urinary System The

More information

Managing Fluid, Diet and Medications

Managing Fluid, Diet and Medications Managing Fluid, Diet and Medications This lesson covers: Fluid and body weight Managing your diet Understanding your medications It is important that you feel comfortable with the information and procedures

More information

8/22/1395 Dr. F. Moeinzadeh

8/22/1395 Dr. F. Moeinzadeh 1 How I treat CKD Dr. Firouzeh Moeinzadeh Táá áàtçà ÑÜÉyxááÉÜ Éy axñ{üéäézç \áyt{tç hç äxüá àç Éy `xw vtä fv xçvxá 2 Aim of this lesson How I diagnosis a CKD patient? How I follow a CKD patient? How I

More information

Edoxaban Switch Programme - Frequently Asked Questions

Edoxaban Switch Programme - Frequently Asked Questions Edoxaban Switch Programme - Frequently Asked Questions What should I tell patients? NHS Tayside is reviewing all patients currently receiving a Direct Oral Anticoagulant (DOAC) for stroke prevention in

More information

Having a pancreas transplant alone (PTA)

Having a pancreas transplant alone (PTA) Having a pancreas transplant alone (PTA) This leaflet explains more about having a pancreas transplant alone (PTA), including the benefits, risks, alternatives, and what you can expect at the time of the

More information

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5)

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5) (Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed (if applicable): Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Donor CMV

More information

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression SHARED CARE PROTOCOL AND INFORMATION FOR GPS Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression Version:

More information

Antibody incompatible kidney transplantation from a deceased donor

Antibody incompatible kidney transplantation from a deceased donor Antibody incompatible kidney transplantation from a deceased donor This leaflet explains more about antibody incompatible renal transplantation from a deceased donor. It will tell you why you were offered

More information

Information for patients with kidney disease attending the Low Clearance Clinic

Information for patients with kidney disease attending the Low Clearance Clinic Information for patients with kidney disease attending the Low Clearance Clinic Why am I attending this Clinic? Your kidneys are not working effectively. This means they cannot do their usual jobs such

More information

Pancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital

Pancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Pancreas Transplantation Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Introduction Selection criteria, New innovation Complications, Success rates, Life expectancy

More information

Chronic Kidney Disease The 6 Pillars. Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre

Chronic Kidney Disease The 6 Pillars. Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre Chronic Kidney Disease The 6 Pillars Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre None Disclosures Objectives 1. Describe evidence-based measures to slow

More information

CKD-MBD CKD mineral bone disorder

CKD-MBD CKD mineral bone disorder CKD Renal bone disease Dr Mike Stone University Hospital Llandough Affects 5 10 % of population Increasingly common Ageing, diabetes, undetected hypertension Associated with: Cardiovascular disease Premature

More information

Paediatric Renal Disease

Paediatric Renal Disease Pharmacy Department Paediatric Renal Disease Andrew.wignell@nuh.nhs.uk NUH Pharmacy At the end of the session you should be able to: Determine the level/type of renal dysfunction in a child and what the

More information